
CAS 167105-80-8
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
6 produits concernés.
Ketorolac Related Compound A (5-Benzoyl-N-(1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)-2,3-dihydro-1H-pyrrolizine-1-carboxamide)
CAS :Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C19H22N2O5Couleur et forme :White PowderMasse moléculaire :358.15287Ketorolac EP Impurity E (Ketorolac USP Related Compound A)
CAS :Formule :C19H22N2O5Masse moléculaire :358.39(1RS)-5-Benzoyl-N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]-2,3-dihydro-1H-pyrrolizine-1-carboxamide
CAS :Couleur et forme :Neatrac Ketoroloc Tris Amide Impurity
CAS :Produit contrôlé<p>Impurity Ketorolac EP Impurity E; Ketorolac USP Related Compound A<br>Applications rac Ketoroloc Tris Amide Impurity (Ketorolac EP Impurity E) is an impurity of Ketorolac (K235650). Ketorolac USP Related Compound A.<br>References Brandl, M. et al.: J. Pharmac. Sci., 84, 1151 (1995);<br></p>Formule :C19H22N2O5Couleur et forme :WhiteMasse moléculaire :358.395-Benzoyl-N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]-2,3-dihydro-1H-pyrrolizine-1-carboxamide, racemic
CAS :5-Benzoyl-N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]-2,3-dihydro-1H-pyrrolizine-1-carboxamide is a drug product that is used in research and development. It is a synthetic compound with niche applications. It has been shown to be metabolized in animal studies and the metabolism pathways have been elucidated. The analytical impurity standard for this drug product is 5-(benzoylamino)-N-[2-(hydroxymethyl)propanoyl]-2,3,-dihydro-1H-pyrrolizine-1 -carboxamide. This compound can be custom synthesized and also has an HPLC standard available.Formule :C19H22N2O5Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :358.39 g/mol






